Insulin Sensitivity and ?-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents - 24/10/15
, Ronald L. Prigeon, MD 2, Deborah A. Elder, MD 1, Todd M. Jenkins, PhD 1, Robert M. Cohen, MD 3, Stavra A. Xanthakos, MD, MS 1, Stephen C. Benoit, PhD 3, Lawrence M. Dolan, MD 1, Stephen R. Daniels, MD, PhD 4, David A. D'Alessio, MD 5, 6Abstract |
Objective |
To test the hypothesis that insulin secretion and insulin sensitivity would be improved in adolescents after Roux-en-Y gastric bypass (RYGB).
Study design |
A longitudinal study of 22 adolescents and young adults without diabetes undergoing laparoscopic RYGB (mean age 17.1 ± 1.42 years; range 14.5-20.1; male/female 8/14; Non-Hispanic White/African American 17/5) was conducted. Intravenous glucose tolerance tests were done to obtain insulin sensitivity (insulin sensitivity index), insulin secretion (acute insulin response to glucose ), and the disposition index as primary outcome variables. These variables were compared over the 1 year of observation using linear mixed modeling.
Results |
In the 1-year following surgery, body mass index fell by 38% from a mean of 61 ± 12.3 to 39 ± 8.0 kg/m2 (P < .01). Over the year following surgery, fasting glucose and insulin values declined by 54% and 63%, respectively. Insulin sensitivity index increased 300% (P < .01), acute insulin response to glucose decreased 56% (P < .01), leading to a nearly 2-fold increase in the disposition index (P < .01). Consistent with improved β-cell function, the proinsulin to C-peptide ratio decreased by 21% (P < .01).
Conclusions |
RYGB reduced body mass index and improved both insulin sensitivity and β-cell function in severely obese teens and young adults. These findings demonstrate that RYGB is associated with marked metabolic improvements in obese young people even as significant obesity persists.
Trial registration |
ClinicalTrials.gov: NCT00360373.
Le texte complet de cet article est disponible en PDF.Keyword : AIRG, BMI, CP, DI, IR, IV, IVGTT, PI, RYGB, SI, T2DM
Plan
| Supported by the National Institute of Diabetes, Digestive, and Kidney, National Institutes of Health (NIH; 5R03DK68228 [to T.I.], R01DK57900 [to D.D.], 1RO1DK59183 [to L.D.]), and the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (8 UL1 TR000077). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Conflict of interest information is available at www.jpeds.com (Appendix). |
Vol 167 - N° 5
P. 1042 - novembre 2015 Retour au numéro
Article précédent
- 50 Years Ago in The Journal of Pediatrics : Imbalance of Liver Phosphorylase and Accumulation of Hepatic Glycogen in a Girl with Progressive Disease of the Brain
- Amy E. Taylor
- Relation of Cardiometabolic Risk Factors between Parents and Children
- Tanya Halvorsen, Antoinette Moran, David R. Jacobs, Lyn M. Steffen, Alan R. Sinaiko, Xia Zhou, Julia Steinberger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?